Apolipoprotein A1 and B

descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 2006 English Publisher:Elsevier BVJournal:Clinics in Laboratory Medicine, volume 26, pages 733-750 (issn: 0272-2712,

Copyright policy )

Authors: Allan D, Sniderman; Santica M, Marcovina;

doi: 10.1016/j.cll.2006.07.007

pmid: 17110237

Apolipoprotein A1 and B

- Summary
- Subjects
- Metrics

Abstract

This article reviews the evidence showing that apolipoprotein (apo) B and A-1 are superior to the conventional cholesterol indices as analytes in laboratory practice, indices of the lipoprotein-related risk for vascular disease, and measures of the adequacy of low-density lipoprotein-lowering therapy.

Related Organizations

University of Washington
United States
McGill University Health Centre
Canada

Keywords

Hyperlipoproteinemias, Apolipoprotein A-I, Humans, Cholesterol, LDL, Coronary Artery Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis, Risk Assessment, Apolipoproteins B

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	43
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%